U.S. Auto Stock News

At the 2026 American Academy of Dermatology meeting, Kenvue (KVUE) used its Neutrogena, Aveeno and Rogaine brands to spotlight new products and clinical data, a move that has put fresh attention on the stock. See our latest analysis for Kenvue. The new dermatology data arrives as Kenvue’s 90 day share price return of 3.57% contrasts with a 1 year total shareholder return decline of 16.87%, suggesting recent momentum has picked up after a weaker stretch. If this kind of product led story has...

How Liberty Global stock has been trading recently Liberty Global (LBTY.A) has seen mixed share price performance, with a 2% decline over the past day, a small gain over the past week, and modest movement over the past month. Over the past 3 months, the stock shows a 16.6% total return and year to date it is up 13.3%. The 1 year total return stands at 16.8%, compared with a 3 year total return of 24.8%. See our latest analysis for Liberty Global. With the share price at $12.35, Liberty...

Expand Energy Corporation recently appointed Marcel Teunissen as Chief Financial Officer and Executive Vice President, effective April 6, 2026, drawing on his leadership background at Parkland Corporation and Shell plc across the energy and natural gas value chain. Teunissen’s experience integrating acquisitions, overseeing large-scale transformation, and managing complex gas portfolios may influence how Expand Energy balances financial discipline with growth ambitions in its natural gas...

In early April 2026, CRH plc continued its US$300 million share buyback program, repurchasing and cancelling over 119,000 ordinary shares and reducing its shares outstanding to about 668.3 million, with just over 5% held as non-voting treasury stock. This ongoing capital return sits alongside a US$5 billion acquisition pipeline through 2026, as CRH targets U.S. infrastructure and data center buildouts while reporting its twelfth consecutive year of margin improvement. We’ll now examine how...

Thermo Fisher Scientific (NYSE:TMO) has entered a collaboration with Precision Health Research, Singapore (PRECISE) on a large-scale proteomics biobank initiative. The PRECISE-SG100K project will use Thermo Fisher platforms, including Olink PEA and the Orbitrap Astral mass spectrometry system, in one of Asia’s largest longitudinal population health studies. The partnership focuses on building regulatory-grade biobank infrastructure and integrating complementary proteomics technologies for...

If you are wondering whether Church & Dwight at around US$96 offers fair value or whether you are paying up for quality, this article breaks down what the current price could mean for you. The stock closed at US$96.16, with a 3.6% gain over the last 7 days, a 4.9% decline over 30 days, a 16.4% return year to date and a 6.1% decline over the last year. Taken together, these figures present a mixed picture of momentum and recent risk sentiment. Recent coverage has focused on Church & Dwight as...

Natera recently received a favorable ruling from the U.S. District Court in Delaware, which upheld the validity of its three asserted MRD patents and granted a 30% ongoing royalty on certain post-injunction revenues from infringing MRD-related product sales by ArcherDx and Invitae. This court decision reinforces Natera’s intellectual property strength in molecular residual disease testing, potentially improving the company’s competitive position and revenue visibility in this specialized...

Recently, analysts highlighted that Freeport-McMoRan is projected to deliver quarterly earnings per share around double the prior year, after repeatedly beating revenue and EPS estimates in past reports. This combination of stronger profit expectations and a history of outperforming forecasts has intensified investor focus on how resilient its earnings power may be. We’ll now examine how this expectation of sharply higher quarterly earnings influences Freeport-McMoRan’s existing investment...

Wondering whether QXO at around US$21.18 still offers value, or if most of the upside is already in the price? This article walks through the key signals that matter. The stock has returned 11.3% over the last 7 days, while the 1 year return sits at 60.5%, with a modest 7.4% return year to date and a mixed longer history that includes a 50.5% decline over 5 years. Recent coverage has focused on QXO's share price strength over the past year and how that contrasts with its relatively flat 3...

Credo Technology Group Holding (CRDO) is back in focus after management highlighted rapid revenue growth tied to hyperscale customers, along with strong interest in products like ZeroFlap Optics and fresh insider selling disclosures. See our latest analysis for Credo Technology Group Holding. Despite a 6.39% 7 day share price return and a US$107.93 latest share price, Credo’s 30 day and 90 day share price returns of 3.92% and 28.25% declines contrast with a very large 1 year total shareholder...

In recent weeks, D-Wave Quantum has reported widening losses, a sharp drop in quarterly bookings, and continued heavy cash use, prompting analysts to reassess their expectations for the business. At the same time, the company is emphasizing its growing bookings pipeline, dual-platform quantum capabilities, and sizeable cash reserves as it pursues commercial adoption despite ongoing losses. Now we’ll examine how mounting concerns about cash burn and weaker bookings could influence D-Wave...

Blackstone (NYSE:BX) has agreed a new partnership with Dubai Aerospace Enterprise to invest about $1.6b per year in commercial aircraft leasing through the Equator initiative. The firm is taking a minority stake in Rowan Digital Infrastructure to support the rollout of sustainable data centers worldwide. Blackstone is also reported to be leading equity funding for Oracle's planned $16.3b Michigan data center project and is assessing a potential investment in an AI focused venture linked to...

In late March 2026, Disney announced plans to cut about 1,000 jobs, mainly in its marketing division, as part of Project Imagine under new CEO Josh D’Amaro to consolidate film, TV and streaming promotion and improve efficiency amid industry pressure on traditional media and streaming economics. This restructuring signals a meaningful shift in how Disney intends to organize and measure its marketing spending, potentially changing the balance between cost control and content promotion across...

JD Bancshares (JDVB) just wrapped up FY 2025 with fourth quarter revenue of US$14.6 million and basic EPS of US$0.97, alongside trailing 12 month revenue of US$56.9 million and EPS of US$3.78, compared with FY 2024 trailing 12 month revenue of US$55.6 million and EPS of US$3.97. Over that same trailing 12 month window, net income moved from US$13.6 million in FY 2024 to US$13.0 million in FY 2025. This may prompt investors to focus on how margins and overall profitability quality shape the...

Investors may be considering whether YETI Holdings, at around US$37.32, is offering fair value right now or if the current price is out of line with its fundamentals. The stock shows a mixed return profile, with a 2.6% move over the last 7 days, a 1.6% decline over 30 days, a 16.8% decline year to date, a 28.4% gain over the past year, and a 55.8% decline over 5 years. Recent coverage of YETI has focused on its position in premium drinkware and coolers and how brand strength may influence...

Hyatt Hotels (H) has been busy adding new flags, from agreements for Grand Hyatt Chennai ECR and Hyatt House Bengaluru Devanahalli in India to fresh openings in Chattanooga and Niagara Falls. Investors now have more growth initiatives to assess. See our latest analysis for Hyatt Hotels. At a share price of $155.69, Hyatt has seen a 2.64% 1 day share price return and an 8.52% 7 day share price return. The 90 day share price return of 7.43% contrasts with a 1 year total shareholder return of...

Constellation Brands (STZ) has just wrapped up FY 2026 with fourth quarter revenue of US$1,920.2 million and basic EPS of US$1.16. The latest trailing twelve month figures show revenue of US$9.1 billion and EPS of US$9.62. Over recent periods, quarterly revenue has ranged from US$1,920.2 million to US$2,515 million, with basic EPS between US$1.16 and US$3.40. This sets up a picture of earnings that now sit against a return to profitability on a trailing basis and margins that investors will...

Hubbell recently reported a past quarter of double-digit growth in net sales, operating profit and diluted EPS, with earnings surpassing analyst expectations even as its full-year earnings guidance came in below consensus forecasts. This combination of strong recent execution and more cautious forward guidance highlights how management is balancing current momentum with prudence about the operating backdrop. Next, we'll examine how this strong earnings beat but softer full-year outlook may...

Nektar Therapeutics (NKTR) is back in focus after new Phase 2b data for rezpegaldesleukin in atopic dermatitis and alopecia areata at the 2026 American Academy of Dermatology meeting, alongside ongoing securities litigation tied to earlier trial conduct. See our latest analysis for Nektar Therapeutics. Rezpegaldesleukin’s new Phase 2b data and plans for a Phase 3 atopic dermatitis program arrive after a sharp swing in sentiment, with a 90 day share price return of 96.05% and a very large 1...

CDW (CDW) is back in focus after a steep slide, as investors rotate out of defensive IT names and question how generative AI, tighter enterprise IT budgets, and a challenged PC refresh cycle could reshape its model. See our latest analysis for CDW. Those worries have already fed into the trading pattern, with the share price moving to US$126.75 after a recent rebound. However, a 90 day share price return of a 5.05% decline and a 1 year total shareholder return of a 12.15% decline highlight...

In recent days, Hut 8 has drawn attention after its River Bend AI data center project and long-term leases with Anthropic, Alphabet, and Google, including a 15-year, US$7.00 billion agreement and a separate 15-year lease that could reach up to US$17.70 billion in revenues, moved further into focus. These multi-decade, hyperscale AI contracts mark a shift toward infrastructure-like, recurring revenue that could materially change how investors view Hut 8’s business mix versus pure Bitcoin...

Charles Schwab (NYSE:SCHW) is launching direct spot Bitcoin and Ethereum trading for its brokerage clients. The new crypto trading capability expands Schwab's digital asset offering beyond indirect products. This move places Schwab in more direct competition with other large financial firms offering crypto access. At a share price of $97.27, Charles Schwab enters this new line of business after a period of mixed returns, with the stock up 3.7% over the past week and 4.4% over the past...

Recent performance snapshot Apple Hospitality REIT (APLE) has drawn investor attention after a recent uptick, with the stock up 3.2% over the past day and 7.5% over the past week, finishing yesterday at US$12.40. See our latest analysis for Apple Hospitality REIT. The recent move to US$12.40 comes after a 7.6% 7 day share price return, set against a softer 90 day share price return and a 1 year total shareholder return of 18.9%. This points to momentum that has been stronger over the longer...

In early April 2026, the Ultra Accelerator Link Consortium ratified updated UALink specifications introducing In-Network Compute, chiplet integration, and standardized manageability to support more efficient, multi-vendor AI accelerator connectivity at scale. This move strengthens the ecosystem around open, interoperable AI interconnects, directly relevant to Astera Labs’ focus on UALink-based products and rack-scale AI infrastructure solutions. We’ll now examine how the new UALink...